Pt-seq unveils the genomic binding pattern of platinum-based drugs
Science Advances · 2025
DOI: 10.1126/sciadv.adx6809 ↗Kurz gefasst
Fachartikel in der Zeitschrift Science Advances, 2025. Verfasst von Chuyun Shao und 10 weiteren Autor:innen. Beteiligte Einrichtung: State Key Laboratory of Gene Function and Modulation Research, School of Life Sciences, Peking University, Beijing, China. Hauptthemen laut MEDLINE: Antineoplastic Agents, Platinum, Genomics. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 55 Literaturangaben. Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Platinum-based drugs (Pt drugs) are widely used in cancer chemotherapy, yet their genome-wide binding patterns remain incompletely understood. Here, we present Pt sequencing (Pt-seq), an antibody-assisted, genome-wide method for mapping Pt-DNA adducts at single-base resolution. By using exo- and endonucleases to remove background, Pt-seq enables robust and sensitive profiling of binding sites for cisplatin, oxaliplatin, lobaplatin, and a Pt(IV) complex. Using Pt-seq, we identified tens to hundreds of binding clusters that are 10 to 20 kilobases in median length and highly consistent among different drugs, predominantly localizing to centromeric and ribosomal DNA regions. In cisplatin-resistant cells, we found significantly reduced binding within these regions. Moreover, we found that mutations in cancer cells can generate previously unidentified binding sites. On this basis, we demonstrated that ICR-191, an acridine orange compound capable of inducing G insertions, enhances cisplatin-DNA binding and sensitizes cells to cisplatin. Collectively, Pt-seq sensitively profiles Pt–DNA interactions and deepens our understanding of the genome-wide effect of chemotherapeutic drugs.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Substanzen
Autor:innen und Institutionen
- State Key Laboratory of Gene Function and Modulation Research, School of Life Sciences, Peking University, Beijing, China.
- Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
- Peking-Tsinghua Center for Life Sciences, Academy for Advanced Interdisciplinary Studies, Peking University, Beijing, China.
- State Key Laboratory of Coordination Chemistry, Chemistry and Biomedicine Innovation Center (ChemBIC), School of Chemistry and Chemical Engineering, Nanjing University, Nanjing, China.
- State Key Laboratory of Pharmaceutical Biotechnology, School of Life Sciences, Nanjing University, Nanjing, China.
- Department of Chemical Biology and Synthetic and Functional Biomolecules Center, College of Chemistry and Molecular Engineering, Peking University, Beijing, China.
ORCID-Profile: Chuyun Shao, Mingyang Li, Liuyi Liu, Xiaoyong Wang, Zijian Guo, Chengqi Yi
Zitieren
APA
Shao, C., Li, M., Liu, L., Bai, D., Yang, J., Liu, C., Cai, L., Wang, X., Peng, J., Guo, Z., & Yi, C. (2025). Pt-seq unveils the genomic binding pattern of platinum-based drugs. Science Advances. https://doi.org/10.1126/sciadv.adx6809
Vancouver
Shao C, Li M, Liu L, Bai D, Yang J, Liu C, et al. Pt-seq unveils the genomic binding pattern of platinum-based drugs. Science Advances. 2025. doi:10.1126/sciadv.adx6809
BibTeX
@article{Shao2025,
author = {Shao, Chuyun and Li, Mingyang and Liu, Liuyi and Bai, Dongsheng and Yang, Jinmin and Liu, Cong and Cai, Linxiang and Wang, Xiaoyong and Peng, Jinying and Guo, Zijian and Yi, Chengqi},
title = {Pt-seq unveils the genomic binding pattern of platinum-based drugs},
journal = {Science Advances},
year = {2025},
doi = {10.1126/sciadv.adx6809}
}
EUVIMED